Cytosorbents (CTSO) Research & Development (2010 - 2026)
Cytosorbents (CTSO) posted Research & Development of $1.0 million for Q1 2026, down 38.36% on a QoQ basis from $1.7 million in Q1 2025, and down 38.36% year-over-year from $1.7 million in Q1 2025.
Cytosorbents (CTSO) Research & Development (2010 - 2026) Analysis & Trends
Cytosorbents' Research & Development history runs 17 years deep, the most recent figure standing at $1.0 million for Q1 2026.
- Quarterly Research & Development fell 38.36% year-over-year to $1.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.9 million (down 11.26% YoY) and the FY2025 annual result came in at $3.4 million, down 32.18% from the prior year.
- Research & Development was $1.0 million for Q1 2026 at Cytosorbents, down from $1.7 million in the prior quarter.
- Across five years, Research & Development topped out at $4.2 million in Q1 2022 and bottomed at -$640040.0 in Q4 2024.
- A 5-year average of $2.8 million and a median of $3.3 million in 2022 frame the typical range for Research & Development.
- Annual changes were most pronounced in 2022 — Research & Development soared 85.95% — and 2024, when it tumbled 115.62%.
- Cytosorbents' Research & Development stood at $3.4 million in 2022, then advanced by 20.42% to $4.1 million in 2023, then slumped by 115.62% to -$640040.0 in 2024, then jumped by 359.83% to $1.7 million in 2025, then plunged by 38.36% to $1.0 million in 2026.
- Business Quant data shows CTSO's Research & Development at $1.0 million in Q1 2026, $1.7 million in Q1 2025, and -$640040.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 767.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 413.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 671.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 516.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 263.30 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 145.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -461.27 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 345.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Cytosorbents | 22.58 Mn | 17.78 Mn | 6.13 Mn | 1.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.03 Mn |
| Mar 31, 2025 | 1.66 Mn |
| Dec 31, 2024 | -640,040.00 |
| Sep 30, 2024 | 1.85 Mn |
| Jun 30, 2024 | 1.52 Mn |
| Mar 31, 2024 | 2.25 Mn |
| Dec 31, 2023 | 4.10 Mn |
| Sep 30, 2023 | 3.75 Mn |
| Jun 30, 2023 | 3.67 Mn |
| Mar 31, 2023 | 4.21 Mn |
| Dec 31, 2022 | 3.40 Mn |
| Sep 30, 2022 | 3.29 Mn |
| Jun 30, 2022 | 4.18 Mn |
| Mar 31, 2022 | 4.24 Mn |
| Dec 31, 2021 | 6.14 Mn |
| Sep 30, 2021 | 4.26 Mn |
| Jun 30, 2021 | 3.70 Mn |
| Mar 31, 2021 | 2.28 Mn |
| Dec 31, 2020 | 2.69 Mn |
| Sep 30, 2020 | 1.75 Mn |